| Dr Bryan Leonard Berghout, DPM | |
|
10821 19th Ave Se, Everett, WA 98208-5103 | |
| (425) 337-7000 | |
| (425) 338-2408 |
| Full Name | Dr Bryan Leonard Berghout |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 26 Years |
| Location | 10821 19th Ave Se, Everett, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255411419 | NPI | - | NPPES |
| 8484388 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | PO00000813 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Foot And Ankle Physicians And Surgeons, Llc | 0345131652 | 2 |
News Archive
The Associated Press: "His health care remake near collapse, President Barack Obama on Wednesday implored lawmakers not to abandon a historic opportunity even as he accepted part of the blame for failing to sell the complex plan to average Americans ... Obama defended his ambitious proposal, saying it would protect most Americans from being rejected for insurance if they get sick, preserve choice of doctors, bring down the federal deficit and provide affordable coverage for millions now uninsured" (Alonso-Zaldivar, 1/27).
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
Patients who are unlikely to benefit from a commonly used immunotherapy for bladder cancer could be identified by a simple blood test, according to researchers at Brighton and Sussex Medical School.
Kewaunee Scientific Corporation today reported results for its second quarter ended October 31, 2015.
› Verified 9 days ago
| Provider Name | Northwest Foot And Ankle Physicians And Surgeons, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1477640779 PECOS PAC ID: 0345131652 Enrollment ID: O20040324000405 |
News Archive
The Associated Press: "His health care remake near collapse, President Barack Obama on Wednesday implored lawmakers not to abandon a historic opportunity even as he accepted part of the blame for failing to sell the complex plan to average Americans ... Obama defended his ambitious proposal, saying it would protect most Americans from being rejected for insurance if they get sick, preserve choice of doctors, bring down the federal deficit and provide affordable coverage for millions now uninsured" (Alonso-Zaldivar, 1/27).
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
Patients who are unlikely to benefit from a commonly used immunotherapy for bladder cancer could be identified by a simple blood test, according to researchers at Brighton and Sussex Medical School.
Kewaunee Scientific Corporation today reported results for its second quarter ended October 31, 2015.
› Verified 9 days ago
| Provider Name | Eastern Podiatry Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1104692219 PECOS PAC ID: 1951448711 Enrollment ID: O20240223001267 |
News Archive
The Associated Press: "His health care remake near collapse, President Barack Obama on Wednesday implored lawmakers not to abandon a historic opportunity even as he accepted part of the blame for failing to sell the complex plan to average Americans ... Obama defended his ambitious proposal, saying it would protect most Americans from being rejected for insurance if they get sick, preserve choice of doctors, bring down the federal deficit and provide affordable coverage for millions now uninsured" (Alonso-Zaldivar, 1/27).
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
Patients who are unlikely to benefit from a commonly used immunotherapy for bladder cancer could be identified by a simple blood test, according to researchers at Brighton and Sussex Medical School.
Kewaunee Scientific Corporation today reported results for its second quarter ended October 31, 2015.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bryan Leonard Berghout, DPM 6405 S 3000 E Ste 201, Salt Lake City, UT 84121-6990 Ph: (801) 266-3113 | Dr Bryan Leonard Berghout, DPM 10821 19th Ave Se, Everett, WA 98208-5103 Ph: (425) 337-7000 |
News Archive
The Associated Press: "His health care remake near collapse, President Barack Obama on Wednesday implored lawmakers not to abandon a historic opportunity even as he accepted part of the blame for failing to sell the complex plan to average Americans ... Obama defended his ambitious proposal, saying it would protect most Americans from being rejected for insurance if they get sick, preserve choice of doctors, bring down the federal deficit and provide affordable coverage for millions now uninsured" (Alonso-Zaldivar, 1/27).
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-5902 during a poster session at the American Association for Cancer Research 102nd Annual Meeting being held in Orlando, Florida, April 2-6, 2011, at the Orange County Convention Center.
Patients who are unlikely to benefit from a commonly used immunotherapy for bladder cancer could be identified by a simple blood test, according to researchers at Brighton and Sussex Medical School.
Kewaunee Scientific Corporation today reported results for its second quarter ended October 31, 2015.
› Verified 9 days ago
Jeffrey C Christensen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1823 37th St Ste A, Everett, WA 98201 Phone: 425-339-8888 Fax: 425-258-6933 | |
Everett Foot Clinic Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 3401 Rucker Ave, Everett, WA 98201 Phone: 425-259-3757 Fax: 425-259-6565 | |
Dr. Sean S Laghaeian, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3927 Rucker Ave, Everett, WA 98201 Phone: 425-339-5407 Fax: 425-339-4207 | |
Kevin L Morris, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3202 Colby Ave, Suite E, Everett, WA 98201 Phone: 425-259-0855 | |
Dr. Jessica Lea Lund, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3927 Rucker Ave, Everett, WA 98201 Phone: 425-339-5407 Fax: 425-339-4207 | |
Dr. Timothy Jarrod Mccord, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3401 Rucker Ave, Everett, WA 98201 Phone: 425-259-3757 Fax: 425-259-6565 |